DEPTH

ISSUE

Is it the same all around U.S.?

Today in the US the consumption and diffusion of opioids pain-relievers are alarmingly high. Those medications are still prescribed to treat not just cancer patients but to cure different kinds of chronic pain from severe to moderate. The highest value of pro-capita consumption is registered in Tennesse with an average 1.096,02 mg for person per year.

Pro-capite consumption of prescription opioids - 2015

legend with exagons
MG of morphine consume per capita AK State: ALASKA Consumption: 757.4 CA State: CALIFORNIA Consumption: 467 NV State: NEVADA Consumption: 1004.5 OR State: OREGON Consumption: 778.5 WA State: WASHINGTON Consumption: 614.6 UT State: UTAH Consumption: 795.2 ID State: IDAHO Consumption: 792.8 AZ State: ARIZONA Consumption: 850.2 CO State: COLORADO Consumption: 580.4 WY State: WYOMING Consumption: 693.7 MT State: MONTANA Consumption: 721.5 NE State: NEBRASKA Consumption: 455.2 SD State: SOUTH DAKOTA Consumption: 477.1 ND State: NORTH DAKOTA Consumption: 416.1 IA State: IOWA Consumption: 502.9 MN State: MINNESOTA Consumption: 387.5 WI State: WISCONSIN Consumption: 640.7 KS State: KANSAS Consumption: 725.9 NM State: NEW MEXICO Consumption: 646.5 TX State: TEXAS Consumption: 420.6 HI State: HAWAII Consumption: 444.9 OK State: OKLAHOMA Consumption: 1026.1 MO State: MISSOURI Consumption: 765.3 IL State: ILLINOIS Consumption: 426.8 AR State: ARKANSAS Consumption: 949.1 LA State: LOUISIANA Consumption: 679.9 MS State: MISSISSIPPI Consumption: 769.6 IN State: INDIANA Consumption: 791.5 KY State: KENTUCKY Consumption: 860.4 TN State: TENNESSEE Consumption: 1096.2 AL State: ALABAMA Consumption: 1049.6 GA State: GEORGIA Consumption: 622.6 SC State: SOUTH CAROLINA Consumption: 811.4 NC State: NORTH CAROLINA Consumption: 808 FL State: FLORIDA Consumption: 670.9 VA State: VIRGINIA Consumption: 585 WV State: WEST VIRGINIA Consumption: 1008.1 OH State: OHIO Consumption: 640.6 MI State: MICHIGAN Consumption: 842.3 MD State: MARYLAND Consumption: 634.2 PA State: PENNSYLVANIA Consumption: 781.4 DE State: DELAWARE Consumption: 1027.6 NJ State: NEW JERSEY Consumption: 659.6 CT State: CONNECTICUT Consumption: 644.6 RI State: RHODE ISLAND Consumption: 557.3 NY State: NEW YORK Consumption: 536 VT State: VERMONT Consumption: 615.9 MA State: MASSACHUSETTS Consumption: 473.4 NH State: NEW HAMPSHIRE Consumption: 775.5 ME State: MAINE Consumption: 856.6

Overdose deaths Rate and prescription opioid - 2016

legend with opioid consuption
AK CA NV OR ID MT UT WY AZ CO NM TX HI OK AR TN MS LA AL GA SC NC WV VA PA MD DE NJ NY VT NH ME MA CT RI FL KS NE SD ND MN WI IA MI IL IN KY MO OH WA

Do you know opioids identity?

Legal opioids are medicines which are chemically very similar to heroin and that act on opioid receptors in the spinal cord and brain to reduce the intensity of pain-signal perception. Those medications can produce also other effects like drowsiness, mental confusion, nausea, constipation, respiratory depression and can induce euphoria, particularly if taken at a higher-than-prescribed dose or administered in improper ways. If used for long-term treatments they lead to dependence.

type of opioid legend
2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 NATURAL AND SEMISYNTHETIC OPIOIDS SYNTHETIC OPIOIDS METHADONE 147.957 deaths NATURAL AND SEMISYNTHETIC OPIOIDS morphine . codeine . oxycodone . hydrocodone hydromorphone . oxymorphone 63.997 deaths METHADONE 64.685 deaths SYNTHETIC OPIOIDS fentanyl . tramadol

ROOTS

How did it all started?

The roots of the current situation can be found in the 90’s when opioid medications in the US gone from being used almost exclusively in hospital treatments to a widespread remedy for pain. In the 80’s the undertreatment of pain was a real social issue and opioid relievers appeared as a super- efficient and (at first) safe solution. Prescriptions for that kind of painkillers raised sharply and, unfortunately, also the deaths for opioid overdose soon started to raise. FDA and other government organizations aware of the rising problem started to work - especially from the early 2000s - by intensifying the control over prescriptions with many new regulations and guidelines.

HOW TO READ IT

Other FDA and governative actions
TEXT approvals of medication

<< scroll right to discover more>>
linea
timeline

How much Purdue Pharma invested?

In the 90’s pharmaceutical companies undertook advertisement campaigns to promote opioids for the wide public. 1996 is often addressed as the year of start for the crisis due to the campaign of Purdue Pharma “I got my life back” in which xyContin was presented as a perfectly safe medicine able to cancel pain from people’s lives. In fact, from 1996 to 2002 Purdue Pharma massively invested in marketing advertising.

2002 2001 2000 1999 1998 1997 1996 500.000 $ Marketing category Expenses in marketing advertising per year Total Sales per year 1 Million $ 1996 1996 139.235.000 $ 270.000 $ 4.502.000 $ 750.000 $ 750.000 $ 600.000 $ 619.000 $ 1997 1997 194.674.000 $ 4.066.000 $ 1.479.000 $ 1.210.000 $ 800.000 $ 608.000 $ 207.000 $ 4.066.000 $ 1.479.000 $ 1.210.000 $ 800.000 $ 608.000 $ 207.000 $ 1998 1998 341.989.000 $ 880.000 $ 510.000 $ 824.000 $ 1.897.000 $ 1.307.000 $ 3.870.000 $ 1999 1999 1.112.000 $ 5.893.000 $ 1.075.000 $ 2.526.000 $ 1.396.000 $ 6.264.000 $ 616.865.000 $ 2000 2000 10.023.000 $ 1.051.000 $ 9.171.000 $ 1.387.000 $ 4.107.000 $ 2.120.000 $ 9.893.000 $ 2001 2001 1.440.000 $ 1.555.000 $ 6.700.000 $ 1.690.000 $ 4.500.000 $ 1.088.000 $ 13.710.000 $ 2002 2002 2.062.000 $ 5.450.000 $ 1.500.000 $ 2.750.000 $ 1.255.000 $ 11.826.000 $ 1.269.864 $ PROMOTIONAL MATERIALS DIRECT MAIL JOURNAL ADVERTISING AGENCY FEE CONVENTIONS SPECIAL PROMOTIONS PROMOTIONAL MATERIALS DIRECT MAIL JOURNAL ADVERTISING AGENCY FEE CONVENTIONS SPECIAL PROMOTIONS Total Sales per year 1 Million $ 500.000 $ Marketing category Expenses in marketing advertising per year total earnings for OxyContin and MS-Contin expenses in marketing for OxyContin and MS-Contin

SPOTLIGHT

Who pays who?

2013-2016

Today the high risks connected to a not strictly necessary and controlled use of opioids are evident but still, a lot of investments are dedicated to the promotion of these medications. In particular, pharmaceutical companies pay considerable contributions to doctors for information campaigns for opioids and in proportion to the number of prescriptions they make. If it’s true that paying doctors for speaking and consulting is legal, on the other hand it is illegal to prescribe specific medicines in exchange for kickback payments. This is causing a vicious cycle which is hard to be stopped and that was only in recent years brought to light. As this pattern grows, lot of concerns regard the infuence this money can have on prescribing opioids over less dangerous alternatives and thus not working in the best interest of the patient.

legend to read the graph
ABBVIE, INC. JAYDEEP JOSHI Hydrocodone BANNER LIFE SCIENCES, LLC DEPOMED, INC. MICHELLE BROWN Tapentadol EGALET US INC Oxycodone ENDO PHARMACEUTICALS INC. Oxymorphone GALENA BIOPHARMA, INC. STEVEN SIMON Fentanyl JANSSEN BIOTECH, INC. JANSSEN PHARMACEUTICALS, INC J ANSSEN RESEARCH & DEVELOPMENT, LLC JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC. MALLINCKRODT LLC Hydromorphone Methadone PERNIX THERAPEUTICS HOLDINGS, INC. PFIZER INC. Morphine PFIZER PHARMACEUTICALS LLC PURDUE PHARMA JOSEPH PERGOLIZZI Buprenorphine PURDUE PHARMA L.P. PURDUE PHARMA OF PUERTO RICO PURDUE TRANSDERMAL TECHNOLOGIES L.P. ROXANE LABORATORIES, INC. DONALD FORTIN Codeine SENTYNL THERAPEUTICS, INC. TEVA PHARMACEUTICALS USA, INC. ZOGENIX INC. 40,000 80,000 120,000 160,000 200,000 240,000 280,000 320,00 0 $
Source: Propubblica

Did you read the leaflet carefully?

There is no simple answer to the reason why such a huge socio-economical phenomenon is happening but the role played by the ease of prescription of these medications, together with incorrect information, seems hard to deny.It is even harder to find a solution avoiding the risk of totally criminalizing substances that are necessary in some cases orpushing addicted to more dangerous and cheaper alternatives once they can’t afford opioids anymore. Anyway, a stricter control over prescriptions looks like an inevitable step to be reached through an intensive collaboration bewteen agencies, doctors and people